Company Profiles

driven by the PitchBook Platform

AsclepiX Therapeutics

Description

Provider of biomimetic anti-angiogenic and anti-lymphangiogenic peptides created to treat ocular diseases. The company develops biomimetic anti-angiogenic and anti-lymphangiogenic peptides for indications in ophthalmology, oncology and for other angiogenesi and lymphangiogenesis-dependent diseases enabling patients and doctors to better treat ocular ailments.

2014

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$175k

Latest Deal Amount

$375k

Total Amount Raised

3

Investors

Description

Provider of biomimetic anti-angiogenic and anti-lymphangiogenic peptides created to treat ocular diseases. The company develops biomimetic anti-angiogenic and anti-lymphangiogenic peptides for indications in ophthalmology, oncology and for other angiogenesi and lymphangiogenesis-dependent diseases enabling patients and doctors to better treat ocular ailments.

Website:

www.asclepix.com

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Drug Delivery
Other Pharmaceuticals and Biotechnology

Primary Office

810 Wyman Park Drive Baltimore, MD 21211United States +1 (410) 657-2627
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AsclepiX Therapeutics's full profile, request a free trial.

    AsclepiX Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AsclepiX Therapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Fast Forward at Johns Hopkins UniversityAccelerator/Incubator000 0000000 0000
    National Eye InstituteGovernment000 0000000 0000
    TEDCOVenture CapitalMinority000 0000000 0000
    Fast Forward at Johns Hopkins University Accelerator/Incubator
    National Eye Institute Government
    TEDCO Venture Capital

    AsclepiX Therapeutics Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Wendy PerrowChief Executive Officer & Board Member
    Jordan Green Ph.DCo-Founder, Board Member & Chief Technology Officer
    Aleksander Popel Ph.DCo-Founder, Board Member & Chief Scientific Officer
    Wendy Perrow Chief Executive Officer & Board Member
    Jordan Green Ph.D Co-Founder, Board Member & Chief Technology Officer
    Aleksander Popel Ph.D Co-Founder, Board Member & Chief Scientific Officer

    AsclepiX Therapeutics Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Wendy PerrowAsclepiX TherapeuticsChief Executive Officer & Board Member000 0000
    Wendy Perrow Chief Executive Officer & Board Member AsclepiX Therapeutics
    Request full access to PitchBook